[Dr.Vad]

И вдогонку к цитате:
...Propecia (финастерид) (т.е., действительно препарат, логически рассчитанный для этой формы; кстати, запрещенный к приему женщинам)...
Очевидно, не совсем верно "запрещен", а не эффективен или не разрешен, но иногда пользуют его в Европе, наверное, "off-label":

J Am Acad Dermatol. 2002 Nov;47(5):733-9.
Hair loss in women with hyperandrogenism: four cases responding to finasteride.

Shum KW, Cullen DR, Messenger AG.

Department of Dermatology, Royal Hallamshire Hospital, Sheffield, UK.

Oral finasteride, a type II 5 alpha-reductase inhibitor, has been shown to increase hair growth and slow progression of thinning in men with androgenetic or male pattern balding (Hamiliton type) but has no affect on hair growth in postmenopausal women with female pattern hair loss (Ludwig type). We describe 4 cases of hair loss with characteristics of both male and female patterns in women with hyperandrogenism in which finasteride has improved or stabilized the alopecia. Improved hair growth was seen after 6 months, 1 year, 2 years, and 2.5 years, respectively. The finding that finasteride treatment improves pattern hair loss in women with hyperandrogenism but does not affect those postmenopausal women with female pattern hair loss without hyperandrogenism supports the concept that not all types of female hair loss have the same pathophysiology.

: J Dermatol. 2002 Oct;29(10):665-9.
Depression circumstantially related to the administration of finasteride for androgenetic alopecia.
Altomare G, Capella GL.

Department of Dermatology, Ospedale Maggiore IRCCS, University of Milan, Italy.
In this paper we report 19 patients (14 males, 5 females; mean age 28.16 years +/- 7.68 SD) out of a series of 23 (17 males, 5 females) who developed a mood disturbance (moderate to severe depression) during treatment with finasteride, 1 mg/day orally, for androgenetic alopecia (Hamilton subtypes III-V; Ludwig subtypes I-II). Depression, which significatively impaired sociofamilial relations, sleep and eating behaviour, was associated to marked anxiety in some cases, developed after 9-19 weeks of treatment with finasteride, and promptly resolved after suspension of the drug. Two patients accepted reintroduction of the drug, and depression relapsed within 2 weeks. Depression as an adverse effect of finasteride has been reported only once. Further studies are needed to confirm our circumstantial observations, which are based on a retrospective series of patients.

Уважаемый Hard!
вспомните Ваше начало дискуссии и далее, если действительно эта тема Вам так интересна, будем дискутировать предметно, лично мне углубляться в данную тематику по тонкостям назначения или ведения не хотелось бы.